CLINICAL TRIALS PROFILE FOR FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
✉ Email this page to a colleague
All Clinical Trials for fluocinolone acetonide; neomycin sulfate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02168478 ↗ | Neo-Synalar Modified 48 Hour Patch Test | Completed | Noah Rosenberg, MD | Phase 4 | 2014-06-01 | A 48 hour patch test performed in healthy volunteers to determine the presensitization (pre-existing allergy) of Neo-Synalar (neomycin sulfate 0.5%(0.35% neomycin base), fluocinolone acetonide 0.025%) Cream . Subjects also receive a positive control (Sodium Lauryl Sulfate) and a negative control (Saline). The primary objective of this study is to determine if any subjects exhibit an allergic reaction which may be indicative of a pre-existing sensitization. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for fluocinolone acetonide; neomycin sulfate
Condition Name
Clinical Trial Locations for fluocinolone acetonide; neomycin sulfate
Trials by Country
Clinical Trial Progress for fluocinolone acetonide; neomycin sulfate
Clinical Trial Phase
Clinical Trial Sponsors for fluocinolone acetonide; neomycin sulfate
Sponsor Name